Search Legal Statement
Contact Link to www.roche.com
Solutions for Diagnostics Countries






Back

Development Channel Program for COBAS INTEGRA® Systems
Make specialty tests part of your routine

Laboratories large and small are faced with the medical necessity of reporting test results faster than ever. While this challenge has become easier for routine tests, quickly processing infrequently ordered specialty tests can mean the difference between timely patient treatment and increased hospital length of stay.

At Roche Diagnostics we address this need by offering one of the broadest clinical chemistry menus on the market with our COBAS INTEGRA® systems. With over 150 assays and applications available on one platform, the COBAS INTEGRA menu far exceeds the testing needs for most laboratories. Nevertheless, there are still times where specialty tests not available from Roche are needed for local medical decisions.

Most laboratories cope with the infrequent demand for specialty tests by either sending them to a reference laboratory or performing them off-line on instruments dedicated to a specific technology. Both options take time and require extra effort and cost.

To help laboratories overcome these challenges, Roche will offer COBAS INTEGRA customers the Development Channel program. This program enables customers to develop assay applications for specialty tests on the COBAS INTEGRA 400 plus and COBAS INTEGRA 800 systems. An intuitive user interface leads the user step-by-step through the tasks needed to create new applications. Once developed, these tests can be processed like any other Roche application.

The Development Channel program gives customers immediate access to the following benefits:

  • Multiple reaction and calibration modes make COBAS INTEGRA systems suitable for many specialty assays
  • Specialty tests are incorporated into the cobas c pack reagent carrier for long onboard stability and simple handling.
  • Disposable microcuvettes to eliminate reagent carryover
  • Reaction volumes as little as 120μl improves the yield from expensive reagents
  • Sample volumes of 2–50μl meaning less tubes need to be drawn
  • An onboard Florescence Polarization module enables applications for FP-based assays
  • A complete range of reaction flags safely allows the fine tuning of applications
  • Up to five Development Channels will be available

Features and Benefits

Faster turn around of all tests
quick availability of final report, faster medical decisions, shorter hospital stays, less administration, more expertise in-house

State of art performance
flexible test settings, multiple reaction modes, absorbance and FP technology, disposable cuvettes, initiative user interface

Cost efficiency
use of current routine platform, no additional hardware or workstations to support, low reaction volumes means more tests per ml


Specifications
Sample materials Biological fluids including whole blood*
(*with decreased immersion depth)
Technologies Photometry
Turbidimetry
Fluorescence Polarisation
Cycle time 10.6sec (COBAS INTEGRA® 800 6sec)
Absorbance wavelengths (nm)
(primary and secondary)
340, 378, 409, 480, 512, 552, 583, 629, 652, 659, 800
Fluorescence wavelengths (nm) 485 (excitation) 515 (transmission)
Reaction modes R1-S, R1-S-SR, R1/R2-S, R1/R2-S-SR
Reaction volumes (μl) 120-245
Sample volumes (μl) 2-50
Measurement range (abs) 0–2A (5mm path length)
Measurement range (FP) 0–500mP
Calculation models   Linear regression, Linear interpolation, Logit / Log 4, Logit / Log 5
On board stability User defined within cobas c pack carriers
Calibration modes User defined – each lot, each pack, or each interval

 

 

Back
© 2009, Roche
See our Legal Statement